Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ZIOPHARM Oncology Inc (NASDAQ:ZIOP)

7.04
Delayed Data
As of Apr 28
 -0.47 / -6.26%
Today’s Change
4.45
Today|||52-Week Range
8.72
+31.59%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Cooper Laurence James Neil
Chief Executive Officer
Sale5/05/2016116,667$6.86$800.3K+2.77%
Belbel Caesar J
Sale12/31/201621,667$5.35$115.9K+28.70%
Lebel Francois /ziopharm/
Executive Vice President-Research & Development
Sale12/31/201621,667$5.35$115.9K+28.70%
Brennan Murray F
Director
Buy11/25/201615,000$6.49$97.4K-2.49%
Brennan Murray F
Director
Sale11/25/201613,483$7.22$97.3K-2.49%
Cooper Laurence James Neil
Chief Executive Officer
Sale12/31/201617,292$5.35$92.5K+28.70%
Fowler Wyche Jr
Director
Sale12/31/201610,664$5.35$57.1K+28.70%
Brennan Murray F
Director
Sale12/31/201610,558$5.35$56.5K+28.70%
Belbel Caesar J
Sale6/01/20166,667$7.74$51.6K-9.04%
Lafond Kevin G
Sale12/31/20169,333$5.35$49.9K+28.70%
Page of 3